BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Enalapril

An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.

297+ PubMed studies analyzed · 66 RCTs · Evidence Score: 49.7

Research Domains

Enalapril has been studied across 15 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 🫁 Liver & Detox, ✨ Skin & Hair. The primary research focus is ❤️ Cardiovascular with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Enalapril, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Rivaroxaban
2 shared targets
Sitagliptin
2 shared targets
Mycophenolic
3 shared targets
darapladib
2 shared targets
Testosterone
3 shared targets
Ciclopirox
3 shared targets
protriptyline
2 shared targets
Rosmarinic
2 shared targets
Histamine
2 shared targets
Losartan
2 shared targets
Loading evidence profile...

This evidence profile for Enalapril is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.